Declaration of interest
A Anagnostou reports institutional funding from Novartis, Aimmune Therapeutics, and FARE (Food Allergy Research and Education) and personal fees (consultation and speaker services) from DBV Technologies, ALK, and FARE. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
Reviewer disclosures
Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.